Abstract: The present invention provides DNA encoding a TADG-15 protein as well as a TADG-15 protein. Also provided is a vector capable of expressing the DNA of the present invention adapted for expression in a recombinant cell and regulatory elements necessary for expression of the DNA in the cell. The present invention further provides for methods of inhibiting TADG-15 expression and/or protease activity, methods of detecting TADG-15 mRNA and/or protein and methods of screening for TADG-15 inhibitors. Additionally, the present invention provides for cell-specific targeting via TADG-15 and methods of vaccinating an individual against TADG-15. The instant invention also includes a kit containing antibodies for the detection of TADG-15 protein. The methods described are useful in the diagnosis, treatment and prevention of cancer, particularly breast and ovarian cancer.
Abstract: The present invention provides a composition of matter, comprising a red blood cell coated a polymeric mixture of polyethylene glycol and albumin. Also provided is a method of blocking blood group antigens on the surface of a red blood cell, comprising the step of contacting said cell with a pharmacologically effective concentration of the composition of the present invention.
Abstract: The present invention provides novel DNA sequences encoding a mouse phosphotriesterase-related protein having the sequence shown in SEQ ID NO. 12. Also provided is a phosphotriesterase-related protein having the sequence shown in SEQ ID NO. 12 and a pharmaceutical composition, comprising the protein of the present invention and a pharmaceutically acceptable carrier.
Type:
Grant
Filed:
November 21, 1994
Date of Patent:
September 3, 1996
Assignee:
Kansas University
Inventors:
James P. Calvet, Xiaoying Hou, Brenda S. Magenheimer, Robin L. Maser